Yasir S. Raouf
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Computational Drug Discovery Methods, Click Chemistry and Applications
Most-Cited Works
- → Advances in covalent kinase inhibitors(2020)308 cited
- → Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia(2021)44 cited
- → PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia(2020)41 cited
- → Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting(2020)39 cited
- → Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer(2019)36 cited
- → Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma(2022)30 cited
- → Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype(2021)26 cited
- → Covalent Inhibitors: To Infinity and Beyond(2024)24 cited
- → Targeting histone deacetylases: Emerging applications beyond cancer(2024)20 cited
- → Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia(2019)20 cited